Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/26971
Title: A comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics
Authors: Ertaş, Mustafa
Baykan, Betül B.
Tuncel, Deniz
Gökçe, Mustafa
Gökçay, Figen G.
Şirin, Hadiye
Deniz, Orhan
Öztürk, Vesile
İdiman, Fethi
Yıldız, Nebil
Sıva, Aksel
Saip, Sabahattin
Göksan, Baki
Ak, Fikri
Aluçlu, Mehmet Ufuk
Duman, Taşkın
Melek, İsmet Murat
Bulut, Serpil
Berilgen, Said M.
Uludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı.
Karlı, Necdet
Zarifoğlu, Mehmet
6506587942
6603411305
Keywords: ID migraine screening test
Migraine
Migraine with aura
American migraine
Primary-care
Headache
Prevalence
Disability
Diagnosis
Burden
Responses
England
Neurosciences & neurology
Issue Date: Jan-2009
Publisher: Sage Publications
Citation: Ertaş, M. vd. (2009). "A comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics". Cephalalgia, 29(1), 68-75.
Abstract: Migraine is more likely to be misdiagnosed in patients with comorbid diseases. Not only primary care physicians, but also specialists might misdiagnose it due to the lack of diagnostic criteria awareness. The ID migraine test is a reliable screening instrument that may facilitate and accelerate migraine recognition. This study aimed to compare the prevalence and characteristics of migraine in a large sample of patients admitted to clinics of ophthalmology (OC), ear, nose and throat diseases (ENTC) and neurology (NC), as well as to validate the use of the ID migraine test in OC and ENTC settings. This was a multicentre (11 cites) study of out-patients admitting either to NC, ENTC or OC of the study sites during five consecutive working days within 1 week. From each of the clinics, 100 patients were planned to be recruited. All recruited patients were interviewed and those having a headache complaint received an ID migraine test and were examined for headache diagnosis by a neurologist, blinded to the ID migraine test result. A total of 2625 subjects were recruited. Only 1.3% of OC patients and 5.4% of ENTC patients have been admitted with a primary complaint of headache, whereas the percentage of NC patients suffering from headache was 37.6%. Whereas 138 patients (19.3%) in OC, 154 (17.3%) in ENTC and 347 (34%) in NC were found to be ID migraine test positive, 149 patients (20.8%) in OC, 142 (16%) in ENTC and 338 (33.1%) in NC were diagnosed with migraine. The sensitivity, specificity, and positive and negative predictive ratios of the ID migraine test were found to be similar in all clinics. An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test. This study validated the ID migraine test as a sensitive and specific tool in OC and ENTC, encouraging its use as a screening instrument.
URI: https://doi.org/10.1111/j.1468-2982.2008.01702.x
https://journals.sagepub.com/doi/10.1111/j.1468-2982.2008.01702.x
http://hdl.handle.net/11452/26971
ISSN: 0333-1024
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Zarifoğlu_vd_2009.pdf133.34 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons